1. Home
  2. EPM vs MOLN Comparison

EPM vs MOLN Comparison

Compare EPM & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolution Petroleum Corporation Inc.

EPM

Evolution Petroleum Corporation Inc.

HOLD

Current Price

$4.47

Market Cap

158.2M

Sector

Energy

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.31

Market Cap

158.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPM
MOLN
Founded
2003
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
158.2M
158.9M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
EPM
MOLN
Price
$4.47
$4.31
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$4.93
$8.38
AVG Volume (30 Days)
413.9K
3.6K
Earning Date
05-12-2026
03-12-2026
Dividend Yield
10.64%
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$43,229,621.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$318.52
P/E Ratio
$90.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.19
$3.36
52 Week High
$5.70
$5.36

Technical Indicators

Market Signals
Indicator
EPM
MOLN
Relative Strength Index (RSI) 49.84 40.55
Support Level $4.38 $4.04
Resistance Level $4.63 $4.63
Average True Range (ATR) 0.15 0.27
MACD -0.04 -0.06
Stochastic Oscillator 16.67 17.37

Price Performance

Historical Comparison
EPM
MOLN

About EPM Evolution Petroleum Corporation Inc.

Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: